Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COMPUGEN LTDCGEN · Entity 6149 | Director · President and CEO | July 29, 2026 | July 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COMPUGEN LTD
Report date July 29, 2026 · Filed July 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.26 · Expires 2036-07-29 | Direct | 200,000 |
Reported balance
After 2026-07-29 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-29 · Grant · Acquired 200,000 · Balance 200,000 F1: This option vests 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: This option vests 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2026 Filed Jul 30, 2026 20:10 UTC | COMPUGEN LTD CGEN · Entity 6149 | GrantShare Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $2.26 | $0.00 |
DisclosureSEC source: 0001178913-26-003725 · zk2635774.xml · derivative · entry 1 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Ordinary Shares · 200,000 shares Expires 2036-07-29 F1 · derivative.exercise_date: This option vests 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:02 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002243 · ownership.xml · derivative · entry 3 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,375 Underlying: Ordinary Shares · 5,000 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F3 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:02 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 5,000 | $3.20 | $16,000.50 |
DisclosureSEC source: 0001178913-26-002243 · ownership.xml · nonDerivative · entry 2 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.205 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 24, 2026 Filed Apr 27, 2026 20:02 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 5,000 | $0.83 | $4,146.00 |
DisclosureSEC source: 0001178913-26-002243 · ownership.xml · nonDerivative · entry 1 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:10 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-002133 · zk2635085.xml · derivative · entry 3 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 19,375 Underlying: Ordinary Shares · 5,000 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F3 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:10 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 5,000 | $2.90 | $14,521.00 |
DisclosureSEC source: 0001178913-26-002133 · zk2635085.xml · nonDerivative · entry 2 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.90 to $2.91 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 14, 2026 Filed Apr 15, 2026 20:10 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 5,000 | $0.83 | $4,146.00 |
DisclosureSEC source: 0001178913-26-002133 · zk2635085.xml · nonDerivative · entry 1 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 11:29 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionShare Option (right to buy) · Derivative | 5,625 | $0.00 Strike: $0.83 | $0.00 |
DisclosureSEC source: 0001178913-26-001988 · ownership.xml · derivative · entry 3 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,375 Underlying: Ordinary Shares · 5,625 shares Expires 2032-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025 F3 · derivative.exercise_date: This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 11:29 UTC | COMPUGEN LTD CGEN · Entity 6149 | SaleOrdinary Shares | 5,625 | $2.21 | $12,412.69 |
DisclosureSEC source: 0001178913-26-001988 · ownership.xml · nonDerivative · entry 2 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,375 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.20 to $2.225 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 01, 2026 Filed Apr 3, 2026 11:29 UTC | COMPUGEN LTD CGEN · Entity 6149 | Exercise / conversionOrdinary Shares | 5,625 | $0.83 | $4,664.25 |
DisclosureSEC source: 0001178913-26-001988 · ownership.xml · nonDerivative · entry 1 Ophir Eran · CIK 0001972103 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.